UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000048065
Receipt number R000054271
Scientific Title Thresholds of invasive physiological indices associated with angina and limited exercise capacity in patients with chronic coronary syndrome
Date of disclosure of the study information 2022/06/15
Last modified on 2022/12/15 14:23:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Thresholds of invasive physiological indices associated with angina and limited exercise capacity in patients with chronic coronary syndrome

Acronym

SYMPTOM REGISTRY

Scientific Title

Thresholds of invasive physiological indices associated with angina and limited exercise capacity in patients with chronic coronary syndrome

Scientific Title:Acronym

SYMPTOM REGISTRY

Region

Japan


Condition

Condition

chronic coronary syndrome

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To identify the thresholds of fractional flow reserve (FFR) and diastolic pressure ratio (dPR) associated with angina or impaired exercise capacity in patients with chronic coronary syndrome (CCS)

Basic objectives2

Others

Basic objectives -Others

To identify the thresholds of FFR and dPR after coronary revascularization associated with improvement of angina or exercise capacity in patients with CCS who undergo percutaneous coronary intervention (PCI)

Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

1) The thresholds of FFR and dPR associated with angina
2) The thresholds of FFR and dPR associated with limited exercise capacity during 6-minute walk test
3) The thresholds of FFR and dPR after PCI associated with the improvement of angina
4) The thresholds of FFR and dPR after PCI associated with the improvement of exercise capacity
5) The thresholds of the gains of FFR and dPR between pre and post PCI associated with the improvement of angina
6) The thresholds of the gains of FFR and dPR between pre and post PCI associated with the improvement of exercise capacity

Key secondary outcomes

1) The distance, the exercise time before the onset of angina, and the proportion of angina during 6-minute walk between patients with and without ischemia

2) RDS score
and SAQ score between patients with and without ischemia

3) RDS score
and SAQ score between patients with and without angina during 6-minute walk

4) The distance, the exercise time before the onset of angina, and the proportion of angina during 6-minute walk between patients with and without ischemia after PCI

5) The distance, the exercise time before the onset of angina, and the proportion of angina during 6-minute walk between patients with and without significant gains of FFR and dPR after PCI

6) Pre and post-test comparison of the distance, the exercise time before the onset of angina, and the proportion of angina during 6-minute walk in patients who did not undergo PCI

7) RDS score and SAQ score between patients with and without ischemia after PCI

8) The pre and post-PCI comparison of RDS score
and SAQ score between patients with and without ischemia after PCI.

9) RDS score and SAQ score between patients with and without significant gains of FFR and dPR after PCI

10) The pre and post-PCI comparison ofRDS score
and SAQ score between patients with and without significant gains of FFR and dPR after PCI

11) The pre and post-test comparison of RDS score
and SAQ score in patients who did not undergo PCI

12) Serum creatinine, eGFR, hemoglobin, HbA1c, LDL cholesterol, BNP, and ejection fraction (EF) between patients with and without ischemia

13) Serum creatinine, eGFR, hemoglobin, HbA1c, LDL cholesterol, BNP, and EF between patients with and without angina during 6-minute walk

14) Serum creatinine, eGFR, hemoglobin, HbA1c, LDL cholesterol, BNP, and EF between patients with and without limited walk distance during 6-minute walk


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients aged 20 years or older at the time of consent acquisition
2. Patients who understand the contents of informed consent by the investigators and sign the consent form written by himself / herself.
3. Patients with chronic coronary syndrome who are judged by the investigators to be indicated for coronary angiography

Key exclusion criteria

1. Patients with left ventricular ejection fraction less than 35%
2. Patients who have a history of coronary artery bypass grafting
3. Patients with unstable hemodynamics
4. Patients with heart failure of NYHA classification III or IV
5. Patients with a limitation in walking due to diseases other than chronic coronary syndrome
6. Patients with severe valvular heart disease
7. Patients on maintenance dialysis
8. Patients with unstable angina and acute myocardial infarction within 1 month

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Atsushi
Middle name
Last name Tanaka

Organization

Wakayama Medical University

Division name

Department of Cardiovascular Medicine

Zip code

641-8509

Address

811-1 Kimiidera, Wakayama City

TEL

073-447-2300

Email

a-tanaka@wakayama-med.ac.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name HIgashioka

Organization

Wakayama Medical University

Division name

Department of Cardiovascular Medicine

Zip code

641-8509

Address

811-1 Kimiidera, Wakayama City

TEL

073-447-2300

Homepage URL


Email

higashio@wakayama-med.ac.jp


Sponsor or person

Institute

Wakayama Medical University

Institute

Department

Personal name



Funding Source

Organization

ZEON MEDICAL INC.

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee of Wakayama Medical University

Address

811-1 Kimiidera, Wakayama City

Tel

073-447-2300

Email

wa-rinri@wakayama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

和歌山県立医科大学(和歌山県)、和歌山ろうさい病院(和歌山県)、新宮市立医療センター(和歌山県)、南和歌山医療センター(和歌山県)、橋本市民病院(和歌山県)、ひだか病院(和歌山県)


Other administrative information

Date of disclosure of the study information

2022 Year 06 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 11 Month 19 Day

Date of IRB

2022 Year 01 Month 07 Day

Anticipated trial start date

2022 Year 06 Month 15 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

prospective observational study


Management information

Registered date

2022 Year 06 Month 15 Day

Last modified on

2022 Year 12 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054271


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name